Navigation Links
BGI and GT Life Sciences, Inc. Report Genome Sequence of CHO-K1 and Provide New Insights into Optimization of Biopharmaceutical Protein Production
Date:8/1/2011

SAN DIEGO and SHENZHEN, China, Aug. 1, 2011 /PRNewswire/ -- BGI, the world's largest genomics organization, and GT Life Sciences, Inc., a privately held biotechnology company that utilizes a proven metabolic modeling and experimental platform to drive the discovery and design of new products and processes for the life sciences field, announced today that their collaborative study on the genomic sequence of the Chinese hamster ovary (CHO) K1 cell line was published July 31, 2011 online in Nature Biotechnology (http://www.nature.com/nbt/journal/vaop/ncurrent/full/nbt.1932.html). The CHO-K1 genome is the first published cell line genome decoded by de novo sequencing and assembly. The study yields a better understanding of the genetics of CHO cells and will accelerate the discovery and development of new recombinant protein therapies.

Chinese hamster ovary (CHO) cell lines are mammalian cells derived from the ovary of the Chinese hamster and are the preferred and most commonly used mammalian hosts today in biological and medical research. These cell lines play an important role in bioprocessing research and the development of therapeutic biopharmaceuticals. Currently the worldwide market for recombinant therapeutic proteins totals more than 99 billion USD in annual revenue from a broad range of products, including monoclonal antibodies, growth factors, hormones, and blood factors.

"Recognizing the importance of CHO cell lines, we and our partners jointly initiated a study of the genome sequence of CHO-K1 cells," said co-leading author of the study Xun Xu, Vice President of Research and Development at BGI and CEO BGI Americas. "The genome sequence and comprehensive annotation of the CHO-K1 cell line provides a useful and powerful tool for scientists in biomedical areas to optimize the production process and improve the yield of therapeutic proteins," he
'/>"/>

SOURCE GT Life Sciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Luminex Corporation Completes Acquisition of EraGen Biosciences, Inc.
2. Luminex Corporation Announces Agreement to Acquire EraGen Biosciences, Inc.
3. Regado Biosciences, Inc. Presents Results of the RADAR Phase 2b Clinical Trial of its REG1 Anticoagulation System
4. Regado Biosciences, Inc. Announces Presentation of the Results of the RADAR Phase 2b Clinical Trial of Its Anticoagulant System REG1 at the i2 Summit During the American College of Cardiology 2011 60th Annual Scientific Session & Expo in New Orleans
5. Regado Biosciences, Inc. Introduces REG3, a Novel Aptamer-Based Inhibitor of Glycoprotein VI and its Matched Active Control Agent, at the American Heart Association (AHA) Scientific Sessions 2010 Meeting
6. Regado Biosciences, Inc. Presents Pharmacokinetic and Pharmacodynamic (PK/PD) Substudy Results From its Phase 2b RADAR Trial at the American Heart Association (AHA) Scientific Sessions 2010 Meeting
7. Regado Biosciences, Inc. Presents Two Abstracts on the Subcutaneous Depot Formulation of Pegnivacogin, a Nuclease-Stabilized RNA Aptamer, Direct Factor IXa Inhibitor and Part of the REG2 Anticoagulant System, at the American Heart Association (AHA)
8. Coronado Biosciences, Inc. Announces Completion of Financings, Management Changes and Development Update
9. Regado Biosciences, Inc. Presents the First-In-Human Clinical Experience with REG2 at the American College of Chest Physicians (ACCP) Coagulation and Heart Disease Sessions in Vancouver, BC, Canada on November 2, 2010
10. Signum Biosciences, Inc. Announces Commercial Launch of Arazine™
11. Ampio Pharmaceuticals to Acquire DMI Biosciences, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... NYACK, N.Y. , July 2, 2015  Before you ... plan ahead so you can stay safe and healthy. Take ... plants #summersafety. Infographic http://nyackhospital.org/summersafety Protect Your ... rays from the sun can increase your risk of skin ... the shade as much as possible, especially during midday hours. ...
(Date:7/2/2015)... DUBLIN , June 25, 2015 ... "Cancer Diagnostics Market by Technology, Imaging and by Application - ... global cancer diagnostics market is expected to reach $13.1 Billion in ... CAGR of 12.9%. The market is dominated by ... , Asia , and Rest of the World ...
(Date:7/2/2015)... Mass. , July 2, 2015   ... and European retinal specialists identify less frequent dosing ... edema (DME), due to the burden on both ... anti-vascular endothelial growth factor (VEGF) injections, which are ... Allergan/Molecular Partners, abicipar pegol, which is in development ...
Breaking Medicine Technology:First Aid Summer Survival Tips from Nyack Hospital 2First Aid Summer Survival Tips from Nyack Hospital 3Global Cancer Diagnostics Market Report 2015 - Technology, Imaging and by Applications Forecasts to 2020 for the $13 Billion Industry 2Retinal Specialists Indicate Strong Desire for DME Therapies Which Induce Greater Vision Gains or are Administered Less Frequently Than Currently Approved Anti-VEGF Therapies 2Retinal Specialists Indicate Strong Desire for DME Therapies Which Induce Greater Vision Gains or are Administered Less Frequently Than Currently Approved Anti-VEGF Therapies 3
... Calif., Dec. 22, 2010 ISTA Pharmaceuticals, Inc. (Nasdaq: ... a 2011 guidance and pipeline update webcast/conference call after ... President and Chief Executive Officer, Vicente Anido, Jr., Ph.D., ... Development, Lauren Silvernail, will provide 2011 guidance, give a ...
... LOUIS, Dec. 21, 2010 Today, Pepex Biomedical, Inc. ... their new nanotechnology-based Trio One-Click blood glucose meter. During ... in close collaboration with Pepex engineers, designed and devolved ... new Trio. These incorporate key requirements of the new ...
Cached Medicine Technology:ISTA Pharmaceuticals Announces 2011 Guidance and Pipeline Update Webcast/Conference Call on January 5, 2011 2Prototypes of Pepex™ Trio™ One-Click™ Meter Delivered 2Prototypes of Pepex™ Trio™ One-Click™ Meter Delivered 3
(Date:7/4/2015)... , ... July 04, 2015 , ... When a hacker gains access to someone’s email ... at the office. On Wednesday, July 1st, the FTC issued a scam alert about ... of a verification process for a password reset instigated by the hacker. All they ...
(Date:7/3/2015)... ... July 03, 2015 , ... On ... for a new SEO training system called "Page One Engine" . The ... generation has received glowing reviews from several well-known marketers. HonestyFirstReviews.com's Tiffany Hendricks has ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... providers, has been retained to lead a national president recruitment for ... in the healthcare industry, B. E. Smith has recently placed more than 1,000 ...
(Date:7/3/2015)... ... July 03, 2015 , ... Talcum powder attorneys representing clients ... existing Talcum Powder Cancer Lawsuit Center website. Just as the previous version did, the ... , offering timely lawsuit updates and ovarian cancer warning information. The site is routinely ...
(Date:7/3/2015)... , ... July 03, 2015 , ... Yisrayl Hawkins, Pastor ... article this week that he says will reveal biblical truth and expose popular lies ... Does Your Bible Say Don’t Have Sex”, immediately goes into the core of the ...
Breaking Medicine News(10 mins):Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 2Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 3Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 4Health News:Page One Engine - Review Of Dori Friend's SEO Training Course Released 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 3Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 3Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2
... ... otologist/neurotologist with Summit Medical Group, has been named to the editorial board of ... ... Medical Group, has been named to the editorial board of Otology/Neurotology. The official ...
... odds for heart attack, stroke, and inflammation may be ... -- The common skin ailment psoriasis may boost the ... probably through a shared inflammatory response, a new Danish ... as a risk factor for cardiovascular disease," study lead ...
... high blood pressure, heart attack, even death, study suggests , ... as jogging is good for the heart, then turbo-charged workouts ... , Not so fast, according to new research by Greek ... the large arteries, suggesting that some types of high-intensity exercise ...
... Your Vision month , SATURDAY, March 13 (HealthDay News) ... economy billions each year in lost productivity, but 90 ... measures, such as having workers wear properly designed and ... critical to successfully completing job-related tasks," James Sheedy, director ...
... appeal, study suggests , SATURDAY, March 13 (HealthDay News) ... great mysteries, and many credit it with the portrait,s ... said Austrian neurologists who used computer-altered images to simulate ... "There is more to Mona Lisa than her elusive ...
... of Public Health Physicians submitted a petition to the US Food and Drug Administration on February 23rd in response ... on public health the products could have in the future. , ... ... ...
Cached Medicine News:Health News:Summit Medical Group Physician Named to Medical Journal Editorial Board 2Health News:Summit Medical Group Physician Named to Medical Journal Editorial Board 3Health News:Psoriasis Tied to Raised Heart Risk 2Health News:Marathoners Face Greater Risk of Artery Problems 2Health News:Eye Health and Safety Should Be Job One 2Health News:There's More to Mona Lisa Than Her Smile 2Health News:There's More to Mona Lisa Than Her Smile 3Health News:Electronic Cigarettes Are Tobacco Products, States AAPHP 2Health News:Electronic Cigarettes Are Tobacco Products, States AAPHP 3Health News:Electronic Cigarettes Are Tobacco Products, States AAPHP 4
The D.O.R.C. Silicone Oil is an ultra purified silicone oil which leads a maximum interfacial tension and minimizes interactions between tissues, cells and endo-tamponades media.(Sterile, 10 ml.)...
ROB-NEL Catheters (100% Latex-Free)...
Urethral Red Rubber Catheters (Latex)...
ULTRAMER Foley Catheter...
Medicine Products: